Dolby Laboratories $DLB Shares Sold by Ninety One UK Ltd

Ninety One UK Ltd reduced its holdings in Dolby Laboratories (NYSE:DLBFree Report) by 2.7% during the 3rd quarter, Holdings Channel reports. The fund owned 410,738 shares of the electronics maker’s stock after selling 11,467 shares during the quarter. Ninety One UK Ltd’s holdings in Dolby Laboratories were worth $29,725,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in DLB. Panagora Asset Management Inc. acquired a new position in shares of Dolby Laboratories during the first quarter valued at $1,293,000. MAI Capital Management raised its position in shares of Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after buying an additional 162 shares in the last quarter. Royal Bank of Canada lifted its stake in shares of Dolby Laboratories by 3.5% in the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock worth $5,491,000 after acquiring an additional 2,298 shares during the period. Focus Partners Advisor Solutions LLC bought a new position in shares of Dolby Laboratories in the first quarter valued at approximately $271,000. Finally, EP Wealth Advisors LLC acquired a new position in shares of Dolby Laboratories during the first quarter valued at approximately $379,000. Institutional investors own 58.56% of the company’s stock.

Wall Street Analyst Weigh In

DLB has been the subject of a number of research analyst reports. Barrington Research cut their target price on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research report on Wednesday, November 19th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday. Rosenblatt Securities lowered their target price on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Wednesday, November 19th. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Sunday, December 28th. Finally, Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Three analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Dolby Laboratories has a consensus rating of “Moderate Buy” and a consensus target price of $92.00.

Read Our Latest Analysis on Dolby Laboratories

Insider Buying and Selling

In other news, EVP Mark Andrew Sherman sold 9,109 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $66.73, for a total value of $607,843.57. Following the transaction, the executive vice president owned 73,054 shares of the company’s stock, valued at $4,874,893.42. This trade represents a 11.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP John D. Couling sold 7,273 shares of the company’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $68.75, for a total transaction of $500,018.75. Following the sale, the senior vice president directly owned 108,065 shares of the company’s stock, valued at approximately $7,429,468.75. This represents a 6.31% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 162,120 shares of company stock valued at $10,906,559 over the last 90 days. 37.93% of the stock is currently owned by insiders.

Dolby Laboratories Stock Down 1.8%

Shares of NYSE:DLB opened at $64.22 on Friday. The company has a market cap of $6.13 billion, a P/E ratio of 24.42 and a beta of 0.89. The company’s fifty day moving average is $66.23 and its two-hundred day moving average is $70.56. Dolby Laboratories has a 12-month low of $64.02 and a 12-month high of $89.66.

Dolby Laboratories (NYSE:DLBGet Free Report) last announced its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The firm had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. During the same period in the prior year, the business earned $0.61 EPS. The business’s revenue for the quarter was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Equities research analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were issued a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, December 2nd. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.2%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s payout ratio is currently 54.75%.

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Recommended Stories

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.